Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Slowmo homolog 2 pseudogene (ENSG00000254182) is annotated as a human pseudogene related by sequence homology to the "slowmo" gene family found in Drosophila and other organisms, but in humans it exists in a non-functional form (pseudogene)[4]. Pseudogenes typically arise from protein-coding genes that have lost their coding potential due to disabling mutations, insertions, or deletions, and therefore do not produce functional proteins[1][3]. Although some pseudogenes can be transcribed into noncoding RNAs and may participate in gene regulation as regulatory RNAs or via mechanisms involving sequence similarity (such as acting as microRNA decoys or engaging in gene conversion), there is no evidence that this particular pseudogene fulfills any functional, regulatory, or disease-related role[2][3]. Pseudogenes are generally not considered valid therapeutic targets because they lack protein-coding function and are not active receptors, enzymes, or transporters[1][3]. The label "slowmo homolog 2 pseudogene" indicates that this entry is not a druggable target and would not be used in standard pharmacological research or drug development. If you are seeking a biologically relevant protein or target, this gene is not appropriate.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Slowmo homolog 2 pseudogene.